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resumo Nas últimas décadas, as nanopartículas magnéticas têm vindo a
ser desenvolvidas para aplicações biomédicas, tais como tratamento
médico e imagiologia.
Em relação ao tratamento médico, as nanopartículas magnéticas têm
sido extensivamente utilizadas em hipertermia, um tratamento que
requere o aquecimento de células cancerígenas mas que não possui
controlo de temperatura local, o que habitualmente provoca danos
em células saudáveis. Esta tese aborda este problema utilizando
nanopartículas de Fe3Se4 cuja temperatura de Curie se encontra
ligeiramente acima de 40 °C.
No que toca à imagiologia médica, nas últimas décadas têm vindo a
ser desenvolvidas novas maneiras que permitam a manipulação do
contraste. Nos dias de hoje, a utilização de agentes de contraste
é comum quando se realiza uma Ressonância Magnética (MRI).
Estes agentes de contraste podem ser moléculas, nanopartículas
ou compostos, que alteram o ambiente magnético e podem depois
aumentar ou diminuir o contraste da imagem obtida. As nanopartículas
de Fe3Se4 aqui apresentadas são também avaliadas como agentes de
contraste para MRI. Para além disto, o desenvolvimento de agentes
de contraste de modo duplo representa uma nova geração, que tira
vantagem dos dois modos de relaxação, permitindo ummaior contraste
entre tecidos doentes e saudáveis. Neste sentido, a presente tese
também reporta o desenvolvimento de um novo método de síntese
que dá origem a agentes de contraste de modo duplo que combinam
nanopartículas de Fe3O4 e complexos organometálicos de Gadolínio.
As sínteses e caracterizações de todas as nanopartículas e
complexos de Gadolínio são apresentadas, bem como avaliações
ecotoxicológicas e citotóxicas das nanopartículas.

keywords Magnetic Nanoparticles, Hyperthermia, Temperature Control, Magnetic
Resonance Imaging, Contrast Agents
abstract In the last decades, magnetic nanoparticles have been developed for
biomedical applications, such as medical treatment and imaging.
In medical treatment, magnetic nanoparticles have been extensively
used in hyperthermia, a treatment that requires the heating of cancer
cells but lacks local temperature control, which often leads to damage
in healthy cells. This thesis addresses this problem using Fe3Se4
nanoparticles that have a Curie temperature slightly above 40 °C.
In medical imaging, the quest for contrast manipulation has been
pursued during the last decades. The use of contrast agents is
nowadays common when performing an MRI. These contrast agents
are molecules, nanoparticles or compounds, that alter the magnetic
environment and can later increase or decrease the contrast of the
obtained image. Fe3Se4 nanoparticles here presented are also
evaluated as contrast agents for MRI. In addition, the development of
dual-mode contrast agents represents a new generation, which takes
advantage of the two relaxation modes, allowing a higher contrast
between healthy and unhealthy tissues. Regarding this, the present
thesis also reports the development of a new synthesis approach to
yield a dual-mode contrast agent that combines Fe3O4 nanoparticles
and a Gadolinium based metal-organic complex.
Synthesis and characterizations of all the nanoparticles and
Gadolinium complexes are presented, as well as the ecotoxicological
and cytotoxic evaluations of the nanoparticles.
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1. Introduction
This Chapter starts by presenting the concepts of nanoparticles and nanomaterials.
Secondly, nanoparticles are presented, as well as some of its applications, namely: (1)
nanoparticles used as Logic Gates, (2) nanoparticles used as heat sources in hyperthermia
and (3) nanoparticles used as contrast agents for Magnetic Resonance Imaging (MRI).
Some theoretical concepts regarding these applications will also be presented.
1.1 What is a nanomaterial?
Nanomaterials are objects which have, at least, one dimension within the nanoscale.
This scale conventionally ranges from one to a few hundred nanometers. A scale of
sizes to enlighten the different orders of magnitude between a millimeter-sized object
and a nanometer-sized object is presented in Figure 1 [1]. According to its origin, these
nanomaterials can be divided in two classes. One corresponds to nano-objects that
appear among nature, for example proteins, viruses, bacteria, nanoparticles produced
during volcanic eruptions or during forest fires, nanostructured crystals and minerals,
among others. The other includes nano-objects made by humans: nanoparticles
produced from diesel or petrol combustion, power stations, and incinerators, and, also,
nano-objects produced through a defined manufacturing process, intentionally [2].
Nanomaterials can also be categorized according to their dimensions: nanoparticles,
with all three dimensions smaller than a few hundred nanometres [3]; nanowires or
nanotubes, with two dimensions within the nanoscale [4]; and nanofilms or nanolayers,
comprehending just one dimension within the nanometer range [5]. Depending on the
applications, nanomaterials can be made of different elements or compounds: metals,
such as gold or silver nanoparticles [6], metal oxides, such as titanium dioxide or iron
oxide nanoparticles [3], and semiconductors, such as silicon or carbon, for example [2].
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Figure 1 – Scale of sizes from an atom to a grain of sand to enlighten the nanoscale.
1.2 What changes at the nanoscale?
The major differences between nanomaterials and bulk sized materials are related to
surface and size dependent effects [7]. At the nanoscale, nanomaterials can exhibit finite
size effects, such as quantum confinement, which appears, for instance, in quantum
dots, and superparamagnetism, which appears in small iron oxide nanoparticles [8].
Concerning the surface, as the radius of an object gets smaller, its surface/volume ratio
increases, which allows more molecules to be anchored onto the surface, for example
[1]. The surface geometry, the presence of surfactant or coating are parameters that
substantially change the nanoparticle properties [9].
1.3 Nanoparticles
Nanoparticles can be classified according to its composition into either organic - including
carbon nanotubes, liposomes, and fullerenes - or inorganic, including quatum dots and
magnetic nanoparticles [10]. Nowadays scientists can produce nanoparticles with several
shapes and sizes, depending on the desired applications. Nanoparticles can be found
in different morphologies such as triangular gold nanoparticles [6], hexagonal boron
nitride nanoparticles [11], spherical [12–14] and cubic [14–17] magnetite nanoparticles,
amongst others [18,19]. There are also specific arrangements of different materials: core-
shell, janus, dumbbell, half raspberry, acorn, and snowman, to name a few. In these
cases, the nanoparticle has two or more different regions made of different compounds
or materials [12,20,21].
Nanoparticles can be produced following two general approaches: by making the
materials smaller, i.e., downscaling, and by constructing nanoparticles from small
building blocks, i.e., upscaling. These two are referred as "top-down" and "bottom-up"
approaches, respectively [22]. In general, there are three different methods for the
synthesis of nanomaterials: chemical, physical and biological. Some chemical methods
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include thermal decomposition, coprecipitation, sonochemical, electrochemical
decomposition, hydrothermal and microemulsion [23, 24]. Examples of physical
methods include aerosol, gas phase deposition, electron beam lithography,
laser-induced pyrolysis, pulsed laser ablation and power ball milling [25]. Some
biological methods are mediated by plants, fungi bacteria and proteins [26].
1.4 Applications of nanoparticles
The use of nanoparticles is known to be promising in several fields: electronics,
catalysis, photocatalysis [27, 28], optics, materials science, engineering, biology and
medicine [29], due to the peculiar properties of matter at nanoscale when compared to
the properties of similar materials in the bulk form. In biology and medicine, the
interplay between nanomaterials and biological systems forms an emerging research
field: nanomedicine [4]. In fact, several nanoparticles have been prepared for diagnose
and treatment, being integrated, for example, in sensors for biological molecules,
hyperthermia or photothermal therapy [1,2].
Magnetic nanoparticles, among the most commonly used ones, are inorganic and zero-
dimensional materials usually with a transition metal ion-based composition (from the
d and f groups of the periodic table) [1]. In addition to their magnetic properties, these
nanoparticles exhibit biocompatibility and low toxicity, which makes them attractive for
biomedical applications [30]. Biomedical applications that use magnetic nanoparticles
are generally classified into in vitro (outside the body) and in vivo (inside the body). In
vitro applications are mainly used in diagnostic processes, such as magnetic separation
and magnetic sensing. In vivo applications include diagnostic processes, such as MRI, as
well as therapeutic applications, for example drug delivery and magnetic hyperthermia
[10].
1.4.1 Logic gates
A logic gate is a physical device that implements a Boolean function, i.e., a device that
performs a logical operation on one or more binary inputs and produces a single binary
output. The last years of research have brought molecules [31, 32] and smart
nanomaterials capable of behaving as logic gates [33–35]. These materials are
especially promising for the design of biosensors [36]. Typically, a biosensor has three
fundamental elements: an input, a recognition mechanism and an output.
Distinguishing himself from a common biosensor, a logical gate-based biosensor
includes the possibility of multiple concurrently inputs, a rather complex biochemical
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reaction to process these inputs (with the built-in Boolean logic), and a digital output,
which is generally presented in a "YES/NO" format [37].
There are three basic logic gates: OR Gate, AND Gate and NOT Gate [38]. In an OR
gate the output will be high (1) if either one or both inputs are high. The output will
the low (0) only if both inputs are low. In an AND gate the output will be high only if
both inputs are high. If any of the inputs is low then the output will be low. The NOT
gate is known as an invertor. In this gate, the output will only be high if the input is
low and vice-versa [39]. Another commonly used gate is the NOR gate. The NOR gate
is a combination of an OR gate and a NOT gate connected in series. The inclusive NOR
gate has an output that is normally high and is only low when any of its inputs are high.
The NOR gate is the reverse form of the OR gate explained before [39].
Different types of gates can be combined in various configurations to construct devices
based on sequential logic. In sequential logic, the output depends not only on the input
signal, but also on the sequence of events. One example of a sequential logic-based device
is the set/reset flip-flop logic gate (SR-latch), explained below [39].
SR-latch
A SR-latch is the simplest bi-stable device working as a memory element, which can be
created by wiring two NOR gates in such way that the output of one feeds back to the
input of another, and vice versa, as shown in Figure 2. The set and reset inputs, which
place this memory element into a high or a low state, are labelled S and R respectively,
and the complementary outputs Q and Q¯ respectively [39].
A truth table of a SR-latch, Table 1, shows the output at a time t (Q(t)), the subsequent
action on S, R, or both and the resulting output at a time t+1 (Q(t+1)). RC stands
for "race condition", where the state Q(t+1) is ill-defined and depends on which S or R
is set low in first place.
Figure 2 – A symbolic representation of a SR-latch.
4
Table 1 – Truth table of a SR-latch
Q(t) S R Q(t+1)
0 0 0 0
0 0 1 0
0 1 0 1
0 1 1 RC
1 1 1 RC
1 0 0 1
1 0 1 0
1 1 0 1
1.4.2 Hyperthermia
Nowadays, hyperthermia is amongst the most studied therapeutic methods for cancer
treatments, such as: breast, cervical, lung, head and neck, central nervous system,
gastrointestinal, genitourinary, paediatric cancers, sarcoma and melanoma [40]. The
term hyperthermia derives from two Greek words "hyper" and "therme", meaning "rise"
and "heat", respectively. Relying on the vulnerability of cancer cells to heating, this
treatment exposes the body tissue to high temperatures (between 39 and 45 °C), using
an external energy source. In fact, in vivo studies have shown that temperatures in
the range of 40-44 °C cause more selective damage to tumour cells [10, 40]. Although
this technique has gained prospects and significant advances, it may also cause several
discouragements and frustration because of undesirable effects, such as blisters, burns
and pain, increasing rapidly in healthy cells [10].
Hyperthermia is divided three major categories: local, regional and whole-body. Local
hyperthermia is generally used for localized diseased tissues near the surface of the skin
or natural body orifices. Regional hyperthermia is generally used for deeper diseased
tissues or when a larger area of treatment is required, for example, in the case of a locally
advanced disease. Regional hyperthermia is achieved by increased perfusion of organs or
limbs through blood heating, by irrigation of body cavities or through other non-invasive
methods such as radiofrequency. Whole body hyperthermia is typically used to treat
metastatic disease. The most common approach to whole body hyperthermia is the use
of a flexible infrared chamber. Other methods may involve simply heating a patient’s
room or wrapping the patient in heated blankets. In addition to these simple ambient
methods of inducing hyperthermia, more complex techniques have been developed that
use infrared, RF, microwave and ultrasound [41,42].
Nanoparticles can be used as heating sources in hyperthermia, based on different
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principles. For example, gold nanoparticles can absorb and scatter incident light and
convert resonant energy to heat, due to its surface plasmon resonance. Other examples
include superparamagnetic nanoparticles that release heat when an alternated
magnetic field is applied [43]. Nanoparticle-mediated hyperthermia is promising in
poorly accessible and deep-seated tumours. With specific coatings, the nanoparticles
are not recognized as invasors by the immune system and thus reach their targets [41].
The hyperthermia method has not been very effective to cure serious cancers because
of basic problems associated with local hyperthermia. These problems include
heterogeneous temperature distribution in tumour mass and incapability to prevent
overheating at the deep-seated tumour region [10]. Arguably, the greater challenge has
been the development of methods to detect the temperatures induced and maintained
during the hyperthermia treatment. Thus, the idea of combining nanoparticles that
can both heat the cells and also somehow indicate the temperature range
appeared [44]. This idea and its development will be explored in this thesis.
1.4.3 Magnetic Resonance Imaging
Magnetic Resonance Imaging is the last application of the Nuclear Magnetic
Resonance (NMR) technique, which is considered a powerful tool in many research
fields: in chemical and pharmaceutical analysis for the investigation of molecular
structure and molecular motion in solids and liquids, in solid state physics to study
physical properties at the atomic level, in biomedicine to obtain information about
organs, cells and tissues [45, 46]. In fact, nowadays, MRI has become one of the most
important techniques in the diagnosis of many diseases, is considered a non-invasive
powerful diagnostic method in medical science, which has shown several advantages,
such as extreme imaging flexibility, non-ionizing, patient harmlessness, high patient
acceptance, high-resolution images with an excellent soft tissue contrast between
different tissues, prevision of physiological parameters, and acquisition of unique
clinical information [47]. Particularly, it should be noted that for some pathologies
MRI reached the highest resolution in images and the fastest acquisition times when
compared to other imaging techniques [48].
How MRI works
MRI is an imaging technique based on the magnetic properties of the nuclei, which is
excited by non-invasive radiofrequency (RF) radiation. The nuclei of some elements,
such as Hydrogen, 1H, have a fundamental angular momentum called spin, which causes
them to behave as tiny spinning magnets, as shown in Figure 3 (a) [47]. When these
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nuclei are placed in an uniform external magnetic field and excited by a radio pulse
tuned to the Larmor frequency, the axis of rotation of the nuclei will precess around
the applied magnetic field direction, as shown in Figure 3 (b). The Larmor frequency,
w0, is proportional to the externally applied magnetic field strength, B0, through the
expression w0 = γB0, where γ is the gyromagnetic ratio [48].
Figure 3 – (a) Behaviour of nuclear spin when in absence or in presence of a magnetic field; (b) Precession
movement of the nuclear spin I around the magnetic field B0.
The NMR experiment is based on the precession of a nuclear spin when immersed in a
static magnetic field. Under this field, the degenerated energy levels become separated,
giving origin to 2s+1 energy levels, whereas s is the total spin quantum number. This
effect is known as the Zeeman effect [48]. As shown in Figure 4, in a magnetic field,
spinning nuclei have lower energy when aligned to the magnetic direction than when they
are opposed to it. Simplifying, it can be considered only the nuclear spin of the hydrogen
nucleus, 1H, which is the most relevant one for MRI. The hydrogen nucleus has s=1/2,
which gives rise to 2 non-degenerated energy levels, E1 and E2. This energy gap is given
by ∆E = γB0 and corresponds to a certain frequency (v = ∆E/h) which is in the range
of radio frequencies [48]. Thus, an RF pulse can change the relative populations between
E1 and E2. After a stimulation by a RF pulse, the atomic nuclei population returns to an
equilibrium state, through a process of relaxation. This relaxation process is described
mainly by two microscopic time constants: the longitudinal one, T1, called nuclear spin-
lattice relaxation time and the transversal one, T2, called nuclear spin-spin relaxation
time. T1 and T2 are material-dependent, thus giving the possibility of distinguishing
different tissues/diseases with a proper analysis of the received signal [48].
The interaction between the magnetic moments of the excited spins and the environment
creates fluctuating local microscopic magnetic fields. These magnetic fluctuations are
linked to the molecular movement [48]. Longitudinal, T1, and transverse, T2, relaxation
times are therefore modulated by the phenomenon of molecular distribution and are
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Figure 4 – Energy difference between spins when aligned to the magnetic field, B0, and opposed to it.
expressed by the generic relationship:
1/Ti = Ri = KE2c f(τc) (1.1)
where:
i = 1, 2
Ri is the relaxation rate,
K is a constant,
Ec is the amplitude of the interaction responsible for the relaxation,
f(τc) is a function of the correlation time, τc, that modulates the interaction.
Although the precession movement around the applied magnetic field does not provide
imaging information, if the external magnetic field is made nonuniform in space, i.e. if
a magnetic field gradient is utilized, then protons at different locations will precess at
different frequencies, thereby creating a relationship between location in the body and
precessional frequency. This method of imaging allows one to map the density of protons
in the body in three dimensions, however, most images are obtained and displayed as
planar cross-sectional images similar to those in Computer Tomography scans [45].
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Contrast agents
The signal intensity of MRI depends not only on the proton density, but also on T1
and T2. Instrumental parameters such as the choice of sequence can also influence the
contrast. Fortunately, T1 and T2 can be modulated by contrast agents. Contrast agents
have to be stable, non toxic, biocompatible and must present efficiency and safety for
the patient before being considered for medical application. The efficiency of contrast
agents relies on their relaxivity, defined as the aptitude to increase the water proton
relaxation rate [48,49].
The two major categories of contrast agents are paramagnetic and superparamagnetic.
Paramagnetic compounds typically affect T1 (positive contrast agents, which exhibit
"bright" contrast) and superparamagnetic compounds affect T2 (negative contrast
agents, which exhibit "dark" contrast). Positive contrast agents reduce the R2/R1 ratio
by reducing T1 while negative contrast agents increase the R2/R1 ratio by reducing T2.
Paramagnetic agents are usually composed of a metal ion which has a permanent
magnetic moment due to unpaired electrons, for example Gadolinium, Gd3+, and a
chelating ligand, such as diethylenetriaminepentaacetic acid, DTPA. The
magnetization of paramagnetic materials, such as Gadolinium complexes, is directly
dependent on the ion unpaired electrons and the number of ions, having no
magnetization in the absence of an external magnetic field. There are several transition
metals and lanthanide metals with unpaired spins, but for the metal to be effective as a
relaxation agent the electron spin-relaxation time must match the Larmor frequency of
the protons. This condition is better met for the Fe3+ and Gd3+ ions [47]. The most
common superparamagnetic agents are made of an iron oxide core covered in a
polymer matrix to prevent aggregation. Superparamagnetic agents form a significantly
larger magnetic moment than the paramagnetic agents.
A new generation of contrast agents comprises the combination of paramagnetic and
superparamagnetic centres, to achieve a situation where both T1 and T2 can be
actuated. Some materials have been developed for this purpose, including
combinations in different constitutions of Gd3+ and iron oxide nanoparticles. Some
examples are Gd-doped superparamagnetic iron oxide nanoparticles [50], core-shell
nanoparticles [51, 52], or microspheres [53]. Yet, the combinations of the two magnetic
centres tend to be performed in several steps, which implies more reactions, resources,
and time.
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1.5 Aim of the thesis
The aim of the thesis is to develop two types of nanoparticles, namely Fe3Se4 and
Fe3O4 nanoparticles, for two different biomedical applications. Fe3Se4 nanoparticles
will be used as a logic gate for the determination of whether or not a temperature
threshold was exceeded during hyperthermia treatment in vitro, where Prostate Cancer
cells are heated with a Near Infrared (NIR) LED. Fe3Se4 nanoparticles will also be
evaluated as contrast agents for MRI, and Fe3O4 nanoparticles will be functionalized
with Gadolinium complexes in order to achieve a dual-mode contrast agent for MRI.
The cytotoxicity of these nanoparticles will be evaluated in Prostate Cancer Cells as
well as its ecotoxycological effect on Xenopus laevis, an amphibian model organism.
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2. Synthesis and Characterization
This Chapter presents the state of the art of synthesis of Fe3O4 and Fe3Se4 nanoparticles,
and describes the selected procedures for this thesis, as well as all the characterization
techniques used to analyse the prepared nanomaterials. It is also presented the innovative
one step phase exchange and functionalization procedure that allows nanoparticles to be
coated with small catechol-based biomolecules.
2.1 Fe3O4 nanoparticles
Iron oxides are usually found in nature and can be easily synthesized in the laboratory
[54]. During the last decade, the synthetic routes for the preparation of iron oxide
nanoparticles have been intensively developed due to its fundamental scientific interest
and its many technological applications [55]. Among these, some of the most interesting
applications have been drug delivery, MRI, magnetic hyperthermia, thermoablation,
bioseparation and biosensing [56, 57]. Bioapplications based on magnetic nanoparticles
have been receiving considerable attention due to the unique advantages nanoparticles
present when compared to other materials. Some of these advantages include the ability
to produce iron oxide nanoparticles with a small economic budget, yielding physically
and chemically stable, biocompatible, and environmentally safe nanoparticles [58,59].
Magnetite (Fe3O4) and maghemite (γ-Fe2O3) are two examples of ferrimagnetic iron
oxides that are widely used in several applications. Magnetite has tetrahedral cation
sites occupied by Fe3+ ions and octahedral cation sites occupied by Fe3+ and Fe2+
ions. The magnetic moments of Fe3+ and Fe2+ have different magnitudes. This means
that even when the spins are placed in an antiparallel arrangement, the net magnetic
moment is different than zero - such arrangement occurs below the Curie temperature
(approximately 850 K). This antiparallel unbalanced arrangement is called
ferrimagnetism. On the other hand, maghemite is ferrimagnetic due to another reason.
Similarly to magnetite, maghemite has two sublattices corresponding to Fe3+ ions
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located on tetrahedral and octahedral sites. The atomic moments within each
sublattice are parallel, although, the two sublattices are unequal in number and
arranged in an antiparallel form, leading to a non zero net magnetization, again in a
ferrimagnetic fashion [60]. Ferrimagnetic iron oxide nanoparticles can be synthesized
through a variety of synthetic methods. Some examples include coprecipitation,
thermal decomposition, hydrothermal and solvothermal synthesis, sol-gel synthesis,
microemulsion, ultrasound irradiation and biological synthesis [22]. Conventionally,
these methods can be divided into aqueous and non-aqueous routes. Aqueous
approaches are commonly used due to their low cost and sustainability. As the most
used aqueous approach, the coprecipitation method consists of mixing iron salts in very
basic solutions at room temperature or at medium temperature (≤ 100°C), under an
inert atmosphere (usually Nitrogen) [23]. However, in this method, control over
particle size, morphology and composition is limited [22]. Regarding this, different
alternative strategies have been developed such as nonaqueous thermal decomposition
methods [14]. A typical difference between a coprecipitation synthesis and a thermal
decomposition synthesis can be observed in Figure 5.
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Figure 5 – Comparison of the coprecipitation and the thermal decomposition methods, according to
shape and size distribution.
In principle, thermal decomposition strategies can be subdivided into hot-injection
approaches, where the precursors are injected into a hot reaction mixture, and
conventional reaction strategies where a reaction mixture is prepared at room
temperature and then heated in a closed or open reaction vessel. Thermal
decomposition methods yield highly crystalline magnetic iron oxide nanoparticles with
a narrow size distribution, through the complete separation of the nucleation and
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growth steps [47]. Iron precursors, such as Fe(acac) (III) or Fe(oleate)3 , have been
constantly used to produce monodisperse iron oxide nanoparticles through thermal
decomposition methods [14]. These iron oxide nanoparticles have been reported by
several researchers as potential nanomaterials for biomedical applications [3, 16,17].
Synthesis of Fe3O4 nanoparticles
This synthesis was adapted from a previously reported one by Guardia et al [3]. In a
round bottom flask, 0.7190 g of Fe(acac) (III) and 2.332 g of Decanoic Acid were mixed
in 50 mL of Dibenzyl Ether. The mixture was purged in vacuum during 1 hour at
20 °C, and then placed under a Nitrogen atmosphere. The mixture was then heated
until 200 °C during 2 hours, with an heating rate of 6 °C/minute. The temperature was
later increased until reflux was observed (around 275 °C) during 1 hour, and then cooled
until room temperature. The nanoparticles were collected through centrifugation and
washed with a mixture of ethanol/hexane (2:1). The nanoparticles were later dried and
collected for storage.
X-Ray Diffraction
X-ray diffraction (XRD) is an analytical technique based on the coherent constructive
interference of X-rays and is used for the study of numerous materials, which allows the
identification of the crystalline phases present on the material, as well as the existence of
amorphous material. In the case of crystalline phases, this technique can give information
about the dimensions of the unit cell, the existence of nanocrystalline material, the
existence of deformations within the lattice, and so on [61].
The Rietveld refinement method was developed for curve fitting of the entire powder
diffraction profile and to allow the extraction of the maximum possible information.
This technique has had a significant impact on various materials sciences. Specifically
on nanomaterials, Rietveld allows, for example, the refinement of lattice parameters,
the detection of distortions, the presence of tensions and the finite size effect. Figure
6 shows an X-ray Diffractogram of a Fe3O4 sample, its Rietveld Refinement and the
corresponding unit cell drawing. Rietveld Refinement was performed using the Software
FullProf Suite© which also gave the necessary information to draw the unit cell on
Software VESTA©1. The X-ray diffractogram presents a typical diffraction pattern of
Fe3O4 nanoparticles showing the fingerprint peaks of Fe3O4. Some small differences
between the experimental and the refined data can be noticed. These may appear due
1FullProf Suite© official website: www.ill.eu/sites/fullprof/
VESTA© official website: jp-minerals.org/vesta/en/
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Figure 6 – X-Ray Diffractogram of Fe3O4 nanoparticles and proposed unit cell. The black line
corresponds to the experimental data collected, the red line represents the obtained Rietveld refinement
and the blue line shows the mathematical difference between the other two.
Table 2 – Dimensions of the Fe3O4 cubic unit cell.
Bulk [62] Refined
a, b, c 8.3916(2) Å 8.3915(2) Å
to small initial reagents or residues that could not be separated during the washing
process of the nanoparticles.
Using the Rietveld Refinement it was possible to refine lattice parameters, which are
presented in Table 2. The average apparent size on the Fe3O4 sample obtained was 24
nm. The size effects were treated with the integral breadth method using the Voigt model
for both the instrumental and intrinsic diffraction peak shape considering a Thompson-
Cox-Hastings pseudo-Voigt convoluted with Axial divergence asymmetry function to
describe the peak shape. The contribution of the instrument to the peaks broadening
was determined by the refinement of the XRD pattern of a LaB6 standard sample (NIST
ref. 660a).
Infrared Spectroscopy
Infrared Spectroscopy is a commonly used technique to detect the vibration frequencies
of several types of bonds [63]. Fe3O4 nanoparticles were analysed through Infrared
Spectroscopy between 4000 and 350 cm−1 and the resulting spectra is presented in
Figure 7. The observed peaks at 650 cm−1 and 560 cm−1 were assigned to the stretching
vibration (ν) between the atoms of Fe and O in the crystalline lattice of Fe3O4.
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Figure 7 – Infrared Spectra of Fe3O4 nanoparticles using the Attenuated Total Reflectance mode.
Transmission Electron Microscopy
In order to observe the morphology of the nanoparticles, Transmission Electron
Microscopy (TEM) was used and the size of the nanoparticles was later determined
using the ImageJ© software. TEM images of the Fe3O4 nanoparticles are shown in
Figure 8. From the TEM images, it can be concluded that the nanoparticles have a
narrowed size distribution centred around 17 nm, and a great control over shape. This
value is close to the average apparent size obtained from the Rietveld Refinement, 24
nm, and this difference can be due to the fact that the XRD analysed Fe3O4
nanoparticles were not from the same batch as the TEM analysed Fe3O4 nanoparticles.
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Figure 8 – Transmission Electron Microscopy images of Fe3O4 nanoparticles.
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2.2 Fe3Se4 nanoparticles
Iron selenides are a family of compounds with a wide range of magnetic properties and
compositions, including the diamagnetic FeSe2, the ferrimagnetic Fe3Se4 and Fe7Se8,
and the antiferromagnetic (and superconductor) FeSe [64]. This rich phase diagram
results in the first hurdle to be overcome while designing of a successful chemical route
for the synthesis of iron selenide nanocrystals: phase purity. The iron/selenium phase
diagram shows that the most Se-rich phase, FeSe2, and mixtures of FeSe2 and Fe3Se4
are the most stable at lower temperatures, while the less Se-rich phases are stable at
higher temperatures, and Fe3Se4 forms at intermediate ones [65]. This means that, if
while aiming to design a route where reactants are mixed at ambient temperature, the
system would cross thermodynamic conditions that favour the formation of FeSe2 before
reaching the conditions for the formation of Fe3Se4 [64]. The use of a hot-injection route
where Fe and Se precursors are mixed above the typical nucleation temperature FeSe2
would avoid this problem [65]. However, a "ramped" route where all reactants are mixed
at room temperature is preferably to a hot-injection route, due to to being a safer and
more reproducible method.
When performing a thermal decomposition method to synthesize Fe3Se4 nanoparticles,
it is necessary to choose an iron and a selenium precursor. A Selenium-Octadecene
(Se-ODC) metal-organic complex was selected due to its reactivity and stability [66].
Several reactional times and different proportions were evaluated, and it was noticed
that the reaction time of synthesis of this precursor affected the phase purity of Fe3Se4
nanoparticles. Metal-organic iron complexes are included in the most used iron
precursors for nanoparticle synthesis [14]. Among these, Fe(acac) (III) and Fe(oleate)3
were considered good candidates for this synthesis. Unfortunately, Fe(oleate)3 is a
multi-step synthesis precursor, i.e., starting with FeCl3 and reacting with sodium
oleate, this precursor is synthesized and then submitted to a drying process that
cannot be easily repeated. The final synthesis step of this precursor yields a
caramel-like compound, which is difficult to weight and manage. This leads to a huge
amount of human error, and reproducibility is compromised. Thus, it was decided to
move forward and explore Fe(acac) (III) as an iron precursor, due to its proven
advantages: it is a commercial powder precursor, it is easy to manipulate, and the
results are reproducible.
In the scope of this thesis, synthetic conditions, for iron selenide nanoparticles (Fe3Se4),
were optimized based on Fe(acac) (III). In fact, the optimization process included about
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80 synthesis of these nanoparticles. Below are described the selected synthesis of the
Selenium precursor (Se-ODC) and the Fe3Se4 nanoparticles.
Synthesis of Se-ODC
This synthesis was adapted from a previously reported one by Bullen et al [66]. In a
round bottom flask, 283 mg of Selenium Powder were dissolved in 154 g of Octadecene.
The mixture was purged under vacuum at 120 °C. After 1 hour, the mixture was then
placed under a Nitrogen Atmosphere and the temperature was increased to 215 °C.
After 10 minutes the reaction was cooled to room temperature and reserved in a flask
for further usage.
Synthesis of Fe3Se4 nanoparticles
In a round bottom flask, 58.5 mg of Fe(acac) (III), 10.2809 g of Se-ODC, 15.3 mg
of 1-Dodecanethiol (DDT) and 23.7 mg of Tetradecylphosphonic acid (TDPA) were
mixed and purged in vacuum at 70 °C. After 1 hour, the mixture was placed under
a Nitrogen atmosphere and heated up to 250 °C during 30 minutes with an heating
rate of 5 °C/minute. The reaction was then cooled until room temperature and the
nanoparticles were washed with hexane, collect through centrifugation and dried for
storage.
X-Ray Diffraction
Similarly to the characterization of Fe3O4, the X-ray Diffraction technique was used in
order to determine the present phase on the Fe3Se4 sample. Rietveld Refinement was
performed using the Software FullProf Suite© which also gave the necessary information
to draw the unit cell on Software VESTA©. The X-ray diffractogram shows a typical
diffraction pattern of Fe3Se4. The Rietveld Refinement allows the possibility of refining
important values such as lattice parameters, which are compared to bulk values in Table
3. After the refinement, the average apparent size obtained for the Fe3Se4 sample was
56.1 nm. In this case, the apparent sized cannot be considered the nanoparticle size
due to the fact that these nanoparticles come in the form of multidomain. These results
show that the nanoparticle unit cell does not suffer from distortion as much as the bulk
unit cell.
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Figure 9 – X-Ray Diffractogram of Fe3Se4 nanoparticles and proposed unit cell.
Table 3 – Dimensions of the Fe3Se4 monoclinic unit cell.
Bulk [67] Refined
a 6.208(2) Å 6.160(3)Å
b 3.541(1) Å 3.532(2)Å
c 11.281(3) Å 11.205(8)Å
α 90.00° 90.00°
β 91.80° 91.50°
γ 90.00° 90.00°
Infrared Spectroscopy
The Infrared spectrum of Fe3Se4 nanoparticles is presented in Figure 10, between 3500
cm−1 and 450 cm−1. The observed peaks at 2921 cm−1 and 2849 cm−1 were assigned
to the stretching vibration (ν) of the O-H link typically present in carboxylic acids.
At 1710 cm−1 it was detected the presence of a small stretching vibration (ν) of the
C=O link, commonly observed on carboxylic acids. At 980 cm−1 a C-O stretching
vibration appeared, which was also another signal of the presence of the carboxylic
group. Although this seems odd, the presence of the carboxylic group can derive from a
surface stabilizer that forms during the synthesis.
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Figure 10 – Infrared Spectra of Fe3Se4 nanoparticles using the Attenuated Total Reflectance mode.
Transmission Electron Microscopy
In order to observe the nanoparticles, Transmission Electron Microscopy (TEM) was
used and the size of the nanoparticles was later determined using the ImageJ© software.
TEM images of the Fe3Se4 sample are shown Figure 11. From the TEM images, it can
be concluded that the nanoparticles have a larger size distribution than that observed
in Fe3O4 nanoparticles, centred around 350 nm, and a great control over shape.
Figure 11 – Transmission Electron Microscopy images of Fe3Se4 nanoparticles.
2.3 Surface functionalization of magnetic nanoparticles
As mentioned before, thermal decomposition methods imply the synthesis of hydrophobic
nanoparticles, which can be considered a disadvantage for biomedical applications [56].
Hence, it is necessary to perform a hydrophobic-hydrophilic phase exchange or some sort
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of surface coating. Often, surface coatings are used to achieve a specific functionalization
[68].
Functionalization strategies usually consist on a first step which aims at covering the
surface with reactive groups (amino, carboxylates, thiols, aldehydes) so as to ensure, at
the second step, the further coupling of biomolecules of interest such as streptavidin or
antibodies. Some strategies include polymers, proteins, protein-resistant MR probes
and hyaluronic acid layers [69]. Although, these surface coatings are usually thick,
which increases the total radius of the nanoparticles. Specially in biomedicine, the size
of nanoparticles can affect the success of its application. Thus, it is common to look for
alternatives that allow: (1) a simple functionalization method and (2) a coating that
does not add much size to the nanoparticles [70]. With that in mind, scientists have
previously developed catechol-based biomolecules to anchor onto the surface of
nanoparticles [71, 72]. This strategy relies on the chemical anchoring of hydroxyl
groups (-OH) onto the surface of Fe3O4 nanoparticles, leaving different organic groups
at the surface available for further linkages. For example, in the case of caffeic acid, the
nanoparticles would be functionalized with carboxylic groups (-COOH), whilst in
dopamine would be functionalized with amines (-NH2). This allows the possibility of a
one-step phase exchange and functionalization with small biomolecules, decreasing the
time and resources used in these processes when compared with the typical two-step
method. Although, these methods tend to use organic solvents (tetrahydrofuran),
which should be avoided as possible, following the Green Chemistry principles, as a
way to reduce toxicity of the final product and the obtained waste [73]. These methods
have been adapted in terms of proportions and the choice of solvent (ethanol) in the
scope of this thesis that led to de development of several different functionalizations as
shown in Figure 12.
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Figure 12 – Possible alternative surface functionalizations of nanoparticles with small biomolecules with
catechol groups: caffeic acid, dopamine and levodopa.
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As will be explored in Chapter 3: Applications, iron oxide nanoparticles can be used as
T2 contrast agents for MRI. Since amines can bind to known T1 contrast agents such as
Gd-DTPA, the idea of combining dopamine and levodopa with such agents could lead
to a functionalized surface in only one step and the development of a T1/T2 contrast
agent.
One-step Phase Exchange and Functionalization
Synthesis
Nanoparticles were dispersed in ethanol with the help of an ultrasonic bath. Then, the
surface agent was added, and the mixture was left stirring under Nitrogen at 50 °C
for 3 hours. The resulted mixture was then cooled and collected. The functionalized
nanoparticles were collected, washed 2 times with ethanol, and then dried in a fume hood.
After adding 2 mL of water and leaving a few minutes dispersing inside an ultrasonic
bath, the particles appeared to be stable in water. Of course, as in any experimental
method, this was not verified 100 % of the time. It was noticed that the stabilization
in water after the procedure often depends on the initial state of the nanoparticles, i.e.,
the longer the nanoparticles were storaged, the more difficult would be to succeed in this
methodology.
The quantities of nanoparticles, surface agent and ethanol varied according to the case:
• A dopamine functionalization was achieved mixing 10 mg of nanoparticles, 50 mg
of dopamine hydrochloride and 10 mL of ethanol.
• A levodopa functionalization included 10 mg of nanoparticles, 60 mg of levodopa
and 10 mL of ethanol.
Zeta Potential
Zeta Potential was performed at a neutral pH in order to determine the surface charge
of the nanoparticles. Table 4 shows the results of the two types of nanoparticles with the
different functionalizations. These results show that nanoparticles coated with dopamine
present a positive (+) charge, which is consistent with the premise that, in this case,
amine groups are left available at the surface of the nanoparticles. The amine group
(-NH2) can be easily protonated (-NH
+
3 ), when in an aqueous solution, thus conferring a
positive charge to the prepared nanoparticles. The nanoparticles coated with levodopa
present a negative (-) charge, which supports the premise that carboxylic groups (-
COOH) are available at the surface of the nanoparticles. The carboxylic group (-COOH)
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can be easily deprotonated (-COO−), when in an aqueous solution, thus conferring a
negative charge to the prepared nanoparticles.
Table 4 – Zeta Potential values for nanoparticles with different coatings.
Sample Zeta Potential (mV)
Fe3Se4@Dopamine +3
Fe3Se4@Levodopa -20
Fe3O4@Dopamine +32
Fe3O4@Levodopa -18
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3. Applications
This Chapter describes the two applications explored in the scope of this thesis: (1)
Logic Gates for a threshold temperature control and (2) contrast agents for Magnetic
Resonance Imaging. First, a state of the art is presented, then the experimental part is
described and the results are discussed. The first application was developed in
collaboration with Dr. Vítor Gaspar and Professor João Mano.
3.1 Temperature threshold in hyperthermia
Temperature is one of the most important parameters in our daily life. For instance,
when transporting food, there are certain temperature limits that should not be crossed
[74, 75]. Also in medicine, hyperthermia treatments require temperature ranges that
cannot easily be detected in situ. It is, then, critical to know at what dose does the
temperature increase locally, above a given threshold [76].
Hyperthermia treatments increase the local temperature of the tumour region to about
42-46 °C, in which cancer cells can be selectively damaged without much harm to the
healthy surrounding tissue. If the temperature goes up above 46 °C, which is known as
thermal ablation, this may result directly in complete necrosis of the cells [10]. Therefore,
the development of temperature monitoring systems that are able to give information
about exceeding these defined thresholds is a significant part of research. Regarding
this, thermoresponsive nanothermometers have been developed to measure, for example,
temperature variations inside living cells [77]. However, many drawbacks still limit the
practicability and thus the usefulness of these approaches. These limitations include poor
biocompatibility, low-temperature resolution, slow response time, complex synthesis,
expensive instrumentation and complex nonlinear responses [78].
Furthermore, temperature monitoring systems can also be based on a set/reset flip-
flop logic gate (SR-latch) that responds to temperature as one of the inputs. This
gate changes state as soon as the temperature increases above a defined threshold and
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keeps memory of that event, even after the temperature drops. The gate remains in
this state until a second kind of input resets it back to the original state. One of the
advantages of devices based on this gate is having a short response time, however they
can only determine if the temperature exceeds a defined threshold, not the exact value
of temperature. Magnetic materials can act as SR-latches due to their natural display of
bisatble responses. Useful materials in this context have a net magnetic moment whose
direction is difficult to change with an external field. Such materials are generally termed
"hard magnets", in opposition to "soft magnets", where the net magnetic moment can
easily follow the external field [79].
3.1.1 Fe3Se4 nanoparticles as logic gates
Fe3Se4 nanoparticles are considered hard magnets and have a magnetic phase transition
slightly above room temperature, which causes the particle to lose its ferrimagnetic
arrangement. The temperature at which this phase transition occurs is called Curie
temperature (TC), and can vary according to several parameters, for example, the size
and crystallinity of the nanoparticle. As observed in Figures 13 (a) and (b), TC tends
to increase according to the crystallite size determined by XRD, as usually found in
finite-size systems.
Below TC the nanoparticles present an hysteretic behaviour, allowing the
magnetization to assume several different values according to the temperature and
magnetic field history of the material. Figure 13 (c) shows the magnetization recorded
as a function of temperature after cooling above TC (60 °C) with (FC) or without
(ZFC) an applied magnetic field. Below 35 °C the curves diverge, and the system is in
a high or a low state, respectively. Above 35 °C the system loses its ferrimagnetic
arrangement and remanent magnetization. Thus, below TC the system can be in, at
least, two different states, which depend on the history of the applied magnetic field
and temperature. Above TC only one state is possible. This fact allows the design of a
logic gate that: (1) if cooled without an applied field is set to a low state; (2) if cooled
with an applied magnetic field is set to a high state. The input "magnetic field" will
take this system from a low to a high state, and the input "temperature" will always
lead the system to a low state. This magnetic behaviour allows Fe3Se4 nanoparticles to
act as a bi-stable gate, according to the latest applied stimuli: magnetic field or
temperature. The gate can be represented by two NOR elements in feedback, with two
possible inputs, a set (S) and a reset (R), and one output (Q or Q¯) (Figure 2).
Figure 14 shows the time diagram of the proposed logic gate. Initially, the system was
24
Figure 13 – (a) Average apparent sizes obtained from Rietveld refinement as a function of TC ; (b) ZFC
Magnetization of Fe3Se4 nanoparticles with different average diameter as a function of TC ; (c) Standard
zero-field cooling (ZFC) and field cooling curves (FC) of Fe3Se4 nanoparticles.
in a low state, which was followed by the application of a magnetic field. This field
led the system into a high state. When the field is removed, the system remains in a
high state due to its hard magnetism, leaving a remanent magnetization. Afterwards,
temperature was raised, which caused the magnetization to drop until a low state was
achieved. When temperature dropped, the system remained in a low state. After this
first sequence, the time diagram shows several other sequences which show that a smaller
variation of temperature achieves the same result. This behaviour mimics one of a SR-
latch, using the magnetic field to set the system into high state and temperature to set
the system into a low state. A true table of the proposed SR-latch is presented on Table
1.
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Figure 14 – Set and reset sequences of Fe3Se4 nanoparticles
3.1.2 Logic gates in cell cultures
Hard magnetic nanocrystals with TC close to room temperature, such as the Fe3Se4
nanoparticles here presented, can give valuable insight into materials and systems
which are sensitive in the same temperature range, such as tissues, cells, biomolecules
and soft materials in general. For instance, Fe3Se4 nanoparticles with a TC close to
40 °C can record information of an event of temperature increase above the normal cell
temperature. Below TC , i.e., in the normal temperature range, the nanoparticles may
have a stable high or a stable low value of the remanent magnetization, Mr, (being the
difference between both at least an order of magnitude), depending on which stimuli
was applied last: a magnetic field or a temperature above TC , respectively.
After setting the Fe3Se4 nanoparticles into a high state by the application of a magnetic
field, a temperature increase above the threshold defined by TC will reset Mr into a low
state, thus recording information about that increase. After reading this information,
the nanoparticles can be set again in a high state, which can be easily performed with
an external magnetic field. This corresponds to a logic gate where temperature and field
are the input stimuli and remanent magnetization is the output, being this gate able to
answer the question "did the temperature went above the threshold defined by TC since
the last time we applied an external field?". In the context of cells, this question arises,
for instance, after the application of targeted hyperthermia, where heat sources placed
close to or inside cells are triggered at distance.
In order to evaluate the behaviour of these nanoparticles as SR-latches in living cells,
an experimental procedure was carried out. Prostate cancer cells (PC-3) were routinely
cultured and grown in cell culture in a temperature-controlled incubator at 37 °C, 5 %
CO2 and in a humidified atmosphere, by Dr. Vítor Gaspar. µ-slide angiogenesis Ibidi
imaging chambers were coated with a nanoparticle suspension until a uniform layer was
formed. Subsequently, MatrigelTM was deposited on top of the nanoparticle layer and
allowed to crosslink at 37 °C for 2 hours. This dual deposition strategy allowed for the
formation of a cell adhesive substrate for PC-3 cells proliferation. Prostate cancer cells
were then seeded and allowed to proliferate during 24 hours. Irradiation was performed
using a 850 nm Near Infrared LED with a power density between 228 and 570 mW/cm2
during 5 minutes. The Fe3Se4 nanoparticles on the wells were magnetized (set in the
high state) using a typical neodymium-iron-boron magnet. The states before and after
the irradiation procedures were measured using a fluxgate magnetometer embedded in
a permalloy foil to decrease the ambient magnetic field and noise at the fluxgate. After
irradiation, cells were incubated for 24 hours at 37 °C. The cells were then washed
and imaged. The graphical explanation of this methodology as well as the resulting
fluorescence microscopy images are presented in Figure 15.
It was observed that for a total irradiation time of 5 minutes, the logic gates indicated
that the temperature threshold of 42 °C was crossed for power densities between the
456 and 570 mW/cm2 range (Figure 16). As observed in Figure 15, the majority of
cells subjected to a temperature below the threshold of the nanoparticles (<42 °C)
were viable. When cells were subjected to a temperature above the threshold of the
nanoparticles (>42 °C), the results show the opposite. These results highlight the use
of the Fe3Se4 nanoparticles to simultaneously gain insight as a quality control
technology for temperature thresholds during treatments, while acting as NIR light
absorbers in anti-cancer hyperthermia. This insight can be explored in temperature
control devices for hyperthermia cellular assays in cell plates, or, if further studied, in
nanothermometers. In an ideal method, the nanoparticles would have been placed near
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Figure 15 – Scheme of the use of the logic gates to record a possible overcome of the 42 °C threshold
temperature during irradiation and fluorescence microscopy micrographs of irradiated PC-3 cells.
the targeted tumour or tissue, and the magnetic signal would have been detected
during the heating process. When Mr would have reach its typical minimum value for
Fe3Se4 nanoparticles (determined before the beginning of the treatment), the heating
would have stopped, and the treatment would have been specific to unhealthy tissues
or cells, and would have not affected healthy ones.
Several other methods are left to explore, such as the combination of Fe3Se4 nanoparticles
with Fe3O4 nanoparticles, where the first ones would act as nanothermometers, whilst
the last ones would act as the heating source through magnetic hyperthermia. It is
thought that Fe3O4 nanoparticles tend to heat more than Fe3Se4 nanoparticles, and so,
with a small amount of Fe3O4 nanoparticles, the heating could be more effective and
the nanoparticle dose could be smaller. One of the advantages of this combination is
that the Fe3O4 nanoparticles are less dangerous to the environment than Fe3Se4, as will
be discussed in Chapter 4: Biological Evaluation, which means that this combination,
where Fe3Se4 nanoparticles are used as a sensor and not as an heating source, could be
safer for the environment and the patient.
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Figure 16 – Remanent magnetization Mr measured by the fluxgate magnetometer on the cell wells before
and after irradiation with a given power during 5 minutes.
3.2 Contrast agents for MRI
As mentioned before, the process of relaxation is a function of the water proton
environment and varies according to the tissues. The signal depends on the
concentration of protons and on nuclear relaxation times, T1 and T2. The last can be
affected by contrast agents, depending on its intrinsic magnetic properties [48].
Contrast agents decrease the proton relaxation time thus reducing the acquisition time
of the image. Contrast agents can be made of paramagnetic or superparamagnetic
materials. Paramagnetic contrast agents usually shorten T1 and superparamagnetic
contrast agents affect mainly T2. Typically, T1 contrast agents, available in the market,
contain Gd3+ complexes, such as Gd-DTPA, and T2 contrast agents are made of iron
oxide nanoparticles coated with Dextran [47,49].
As mentioned before, a new generation of contrast agents comprises the combination
of paramagnetic and superparamagnetic centres, to achieve a situation where both T1
and T2 can be actuated. Some materials have been developed for this purpose, yet, the
combinations of the two magnetic centres tend to be performed in several steps, which
implies more reactions, resources, and time.
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In the scope of this thesis different types of Gd3+ functionalized Fe3O4 nanoparticles were
developed to act as a dual-mode contrast agents for MRI. This was achieved through
the surface functionalization of these nanoparticles with new organic Gd3+ complexes
that result from a modification of the know Gd-DTPA complex: the carboxylic groups
of DTPA reacted with levodopa and dopamine, two known amines. The advantage of
using dopamine and levodopa as substitutes for the carboxylic groups relies on the fact
that these two biomolecules are part of the catechol family, which, as explained before
promotes the linkage onto the surface of iron oxide nanoparticles, through the hydroxyl
groups (-OH).
In addition to the dual-mode contrast agents, iron selenide nanoparticles were also
evaluated as T2 contrast agents due to magnetic phase transition near room
temperature.
In the frame of this application several tasks were performed, namely the nanoparticle
synthesis in organic medium - which was described in the Chapter 2: Synthesis and
Characterization -, to guarantee a controlled shape and size distribution; and organic-
aqueous phase transfer and functionalization with Gd3+ complexes, achieved by the
linkage of small catechol based molecules onto the surface of the nanoparticles, in an
one step methodology.
The graphical abstract of the proposed synthesis for dual-mode contrast agents is
presented in Figure 17.
3.2.1 T1 contrast agents
Gd3+ based contrast agents
Gadolinium is very toxic in its hydrated form [Gd(H2O)8]3+. The leaking risk and toxic
of Gd3+ ions, the low relaxivity and the short half-lives of the compounds limit the
application of Gd3+-based agents. To avoid toxicity while maintaining the magnetic
and electronic properties of this ion, paramagnetic Gadolinium complexes have been
used. Further, the ligand complexation to the metal has to leave free coordination
sites so that one or several molecules of water can link to the metal, thus increasing
the relaxivity. The first Gadolinium complexes commercially available were Magnevist®
(Gd-DTPA) and Dotarem® (Gd-DOTA). There are other DTPA derivatives currently
being developed, which can soon turn into new contrast agents when complexed with
Gd. Mainly, these derivatives are synthesized through a general reaction between DTPA
and an amine, as shown in Figure 18 [80]. From this typical DTPA-bisamine synthesis,
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Figure 17 – Organic synthesis of Gd3+ complexes and surface functionalization of nanoparticles.
the idea of combining a molecule with amines and catechol groups appeared in order to
link Gd-DTPA derivatives onto the surface of Fe3O4 nanoparticles through the hydroxyl
groups (-OH) [81]. Two catecholamines were selected for this purpose: dopamine and
levodopa. Below the synthesis for the preparation of the Gadolinium complexes are
described, as well as the used characterization techniques.
Synthesis of DTPA-bisanhydride
In a flask, 15.734 g of DTPA, 16.4788 g of acetic anhydride and 20 mL of pyridine were
added. The mixture was then heated up to 65 °C during 24 hours in an open atmosphere.
After the reaction, the product was filtered under vacuum and washed twice with the
following procedure: 3 × 40 mL of acetic anhydride and 60 mL of acetonitrile. The
obtained solid was then dried overnight in an oven set at 60 °C, yielding a white solid.
Elemental Analysis: 45.14 % Carbon, 5.12 % Hydrogen, 11.33 % Nitrogen.
13C NMR (Solid State, 400, 12 kHz): δ 44 (c), δ 52 (d), δ 53 - δ 54 (e), δ 57 (b), δ 168.5
(a), δ 171.1 - δ 175 (f ). This represents a tentative to propose the peak assignments.
The spectra and structure of this compound is shown in Figure A1.
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Figure 18 – Synthesis of DTPA-bisamine derivatives.
Synthesis of DTPA-bisdopamine
In a flask, 2.5624 g of dopamine • HCl and 2.8336 g of the DTPA-bisanhydride previously
prepared were dissolved in 200 mL of distilled water and heated up to 50 °C during
5 hours at an open atmosphere. After the reaction, the mixture was left in a glass until
precipitation was observed (3-5 days). The precipitated was then centrifuged and dry in
an oven set between 40 and 60 °C and later collected to storage.
Elemental Analysis: 42.70 % Carbon, 5.65 % Hydrogen, 10.34 % Nitrogen.
13C NMR (Solid State, 400, 12 kHz): δ 44 (j), δ 52.5 - δ 61 (b, c, d, e, g, i), δ 116 - δ
122.5 (k, l, o, p, q), δ 142 - δ 145 (m, n), δ 168.5 - δ 175.5 (a, f, h). This represents a
tentative to propose the peak assignments. The spectra and structure of this compound
is shown in Figure A2.
Synthesis of DTPA-bislevodopa
In a flask, 2.5624 g of levodopa and 2.8336 g of the DTPA-bisanhydride previously
prepared were dissolved in 200 mL of distilled water and heated up to 50 °C during
5 hours at an open atmosphere. After the reaction, the mixture was left in a glass until
precipitation was observed (3-5 days). The precipitated was then centrifuged and dry in
an oven set between 40 and 60 °C and later collected to storage.
Elemental Analysis: 48.65 % C, 5.46 % H, 9.01 % N.
13C NMR (Solid State, 400, 12 kHz): δ 37 - δ 53 (b, c, d, k), δ 54 - δ 61 (e, g, j), δ 115.5
- δ 127 (l, m, n, p, q), δ 143 - δ 144 (o, n), δ 168.5 - δ 177 (a, f, h, i). This represents a
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tentative to propose the peak assignments. The spectra and structure of this compound
is shown in Figure A3.
Gadolinium Complexation
1.5 g of GdCl3• 6 H2O and 3 g of the previously prepared DTPA bis amine were dissolved
in 90 mL of distilled water. The pH was adjusted to 5.8 and the reaction was carried
out at 70 °C during 3 hours. After the reaction, the mixture was left in a glass until
precipitation was observed (3-5 days). The precipitated was then centrifuged and dry in
an oven set between 40 and 60 °C (during 1 week) and later collected to storage.
Infrared Spectroscopy
Infrared Spectroscopy was performed as a complementary characterization technique
in order to identify organic groups and also to be able to detect differences between
vibrational modes on different compounds.
Figure 19 shows two groups of Infrared spectra. On the left, Dopamine derivatives of
DTPA and the corresponding Gadolinium complex. The main bands that stand out
Figure 19 – Infrared Spectra of DTPA derivatives and Gadolinium complexes.
correspond to the stretching vibrations (ν) of the C=O link characteristic of the
carboxylic group (present at 1630 cm−1 in DTPA, DTPA-bis anhydride and
DTPA-Dopamine) and the monomer C=O (present at 1730 cm−1 in DTPA and
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DTPA-Dopamine). After the complexation with Gadolinium, these bands disappear
and a new band appears around 1580 cm−1, which is denominated amides II, and is
considered the fingerprint of an amide (-CONH2) containing compound [82].
Levodopa derivatives of DTPA and the corresponding Gadolinium complex are presented
on the right part of Figure 19. Similarly with the Dopamine derivatives, the Levodopa
ones present the same vibrational bands proving that the linkage between Dopamine
and DTPA is the same as Levodopa with DTPA, and that during the complexation to
Gadolinium, an amide link is created [82].
Magnetic properties
During the phase exchange procedure, it was noticeable that only the Fe3O4 coated
with Gd-DTPA-bislevodopa complex resulted in stable ferrofluids. Following this, the
Gd-DTPA-bislevodopa complex was evaluated in terms of magnetic properties, namely
magnetic susceptibility. Figure 20 shows the magnetic susceptibility of the Gd-DTPA-
bislevodopa complex as a function of temperature and its Curie law adjust. From this
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Figure 20 – Temperature dependence of susceptibility and Curie law adjust.
data, it is possible to calculate the relative amount of Gd3+ ions, using the Curie law:
χ =
C
T
= n
(g µB)
2 s (s+ 1)
3 kB T
(3.1)
where n is the number of Gd3+ ions per unit of mass. From this adjust, C can be
determined. Since almost all the parameters of the equation are constants, and assuming
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s = 7
2
, it is possible to estimate n. The calculated value for n using the Curie law
adjust was 4.87 × 1020 Gd3+ ions per gram, which is similar to the "theoretical" value
(calculated using the molecular mass of the compound) 6.6 × 1020 Gd3+ ions per gram.
It is noticeable that the calculated value using the Curie law adjust is smaller than the
"theoretical" one. This means that there are only approximately 74 % of the expected
Gd3+ ions in the sample.
3.2.2 T2 contrast agents
Fe3Se4 nanoparticles
As mentioned before Fe3Se4 nanoparticles are considered hard magnets and have a
magnetic phase transition slightly above room temperature, which also makes them
interesting to use as contrast agents. In fact, since these particles change their
magnetic behaviour according to temperature, the MRI signal is also thought to
change and so these particles can act as thermometers, using image contrast to define
which zones of the body are warmer than usual.
The synthesis of Fe3Se4 nanoparticles is described in Chapter 2: Synthesis and
Characterization, and the magnetic studies were presented and discussed in the
previous section. MRI studies of Fe3Se4 nanoparticles were performed, and values of
T1 and T2 were collected as a function of temperature (Figure 21). From top to
bottom, the first pannels shows the R1 and R2values of Fe3Se4 nanoparticles as a
function of temperature.
Roch et al [83] proposed a heuristic model, where R1 and R2 are expressed as the sum of
two contributions (corresponding to the low and high anisotropy limits). For relatively
low fields and high temperatures, the approximation µB
kBT
1, the most relevant terms are
the pre-factors C1 and C2 given by 3.2:
C1 =
(
32pi
135.000
)
γ2Hµ
2
SP
(
NSP
RD
)
=
32
16
C2 (3.2)
Where µ is the magnetic moment of the nanoparticles, N the nanoparticles density, R
their radius and D the diffusion coefficient. Concerning the themperature dependence
around the Curie temperature, the most relevant term is µ2(T), which in turn is
proportional to χT [84]. So, it is expected to see a similar temperature dependence on
R1, R2 and χT curves. Indeed, the R2 plot presents a similar shape to the χT plot.
Although these results show to be promising, this part of the thesis requires further
studies.
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Figure 21 – MRI measures of Fe3Se4 nanoparticles at 7,2 MHz.
3.2.3 Dual-mode contrast agents
As mentioned before, the strategy for the synthesis of dual-mode contrast agents was to
combine catecholamines, dopamine and levodopa, to link both to Gd-DTPA complexes
(using the amine group) and the nanoparticles (using the hydroxyl group). The result of
this combination was only successful for levodopa, yielding stable water-based ferrofluids.
One step Phase Exchange + Functionalization
10 mg of nanoparticles were dispersed in 50 mL of ethanol in an ultrasonic bath. Later,
624 mg of the Gadolinium complex were added and the mixture was left stirring under
Nitrogen at 50 °C for 3 hours. The resulted mixture was then cooled and collected. The
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functionalized nanoparticles were collected, centrifuged, and then dried in a fume hood.
After the addition of 2 mL of water and a few minutes of dispersion inside an ultrasonic
bath, the particles appeared to be stable in water.
This procedure was performed with different ratios of nanoparticle/complex, but only
proved to be successful for the Gd-DTPA-bis levodopa complex.
Zeta Potential was performed in order to evaluate the charge signal at the surface of
the nanoparticles coated with Gd-DTPA-bis levodopa, and the average result obtained
was -22.83 mV, which is consistent to the results obtained previously with nanoparticles
with levodopa coatings, showing that the carboxylic groups (-COOH) are left available
at the surface of nanoparticles.
Infrared Spectroscopy
The Infrared spectra of Fe3O4 nanoparticles coated with the Gd-DTPA-Levo complex is
presented in Figure 22, where the main band is situated at 1580 cm−1 and corresponds
to the typical Amides II band [82].
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Figure 22 – Infrared Spectra of Fe3O4 nanoparticles functionalized with the Gd-DTPA-Levodopa
complex.
During the timing of this thesis it was not possible to evaluate these nanomaterials for
its capacity of being used as contrast agents, in order to conclude this work. Although,
this is one of the tasks to be completed during the next few months.
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4. Biological Evaluation
Due to the increased production of nanoparticles, it is important to know the effects of
these materials in aquatic environments and their interaction with aquatic living species1.
Regarding this, the first part of this Chapter starts by presenting an ecotoxicological
evaluation of the nanoparticles, mainly the effects of these nanoparticles in Xenopus
laevis tadpoles, used as model organisms. This ecotoxicological evaluation was conducted
by Pedro Nunes, a Master student supervised by Dr. Isabela Lopes that collaborated
with this thesis and will soon present his own.
The second part of this Chapter focuses on the effects of these materials in living cells,
which is important when developing materials for biomedical applications. Thus, it
is presented a cytotoxic evaluation of Fe3Se4 nanoparticles coated with dopamine in
prostate cancer cells, which was performed by Dr. Vítor Gaspar.
4.1 In Vivo ecotoxicological evaluation
The African clawed frog (Xenopus laevis) is an amphibian model and widely employed
for studies on genomics, endocrinology, toxicology and developmental biology. Xenopus
laevis is an anuran amphibian from the Pipidae family, which originated in the African
continent, where it appeared in several countries such as Angola, Cameroons, Congo,
Zambia, among others. This species was considered invasive while being introduced in
European countries, such as Portugal, France and the United Kingdom [85]. Nowadays
this species is actually thriving, often increasing, as it has high reproductive potential,
posing serious problems to some native species. A brief taxonomy of Xenopus laevis is
presented in Table 5 [85].
Xenopus laevis has many advantages as a model organism, such as: (1) an easy regulation
of reproduction; (2) the anaesthesia is accomplished by immerging in a narcotic solution;
1Unfortunately, the majority of residues from industry is still being sent to aquatic environments.
Although this is a huge environmental problem, it is not discussed in the scope of this thesis, only
acknowledged.
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Table 5 – Xenopus laevis Taxonomy
Kingdom Animalia
Phylum Chordata
Class Amphibia
Order Anura
Family Pipidae
Genus Xenopus
Species Xenopus laevis
(3) the organism is docile, harmless and easy to handle, thus accidental injury to the
researcher can be avoided and (4) the organism can be kept easily and inexpensively [86].
Species maintenance
Adult organisms were maintained in glass aquariums. The room temperature was kept
at 23 °C and the light availability was regulated to achieve 16 hours of light and
8 hours of obscurity, simulating a regular outdoor day. The population of adult
organisms included 10 males and 32 females, which allowed the possibility of 320
different couples for reproduction purposes (organisms were chosen randomly
concerning genetic variability).
The tadpoles (Figure 23) were kept in the same room conditions as the adults, but in
smaller plastic recipients containing FETAX2 medium, until used in any assay or died
naturally. They were fed with common fish food (TetraMinTM from TetraTM ) every
other day. The whole experimental procedure was performed recurring to Xenopus
laevis tadpoles rather than adult organisms, due to ethical concerns, namely animal
experimentation issues.
Figure 23 – Xenopus laevis tadpole.
2FETAX is a water-based culture medium containing different salts - such as CaCl2 , CaSO4, KCl,
MgSO4, NaCl and NaHCO3 - that is commonly stored within a pH range of 8±0.03 at room temperature.
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Reproduction and egg harvesting
Eggs of the model organism were obtained by inducing egg laying via commercial Human
Chorionic Gonadotropin (HCG) dorsal lymph sac injection, 12 to 16 hours prior to the
desirable egg laying moment. The injected animals were subjected to a recovery time
of 24 hours in the dark, before being returned into their aquariums, to prevent possible
extra egg laying events occurring while in their captivities. This organisms need about
3 months of resting before being submitted to the same procedure, which makes them
capable of doing so 4 times a year.
Toxicological Assays
The design of the assay consisted of 5 tadpoles in clear glass containers with 300 mL of a
dispersion of nanoparticles in FETAX3, for different concentrations and a control group
with 4 replications each. The organisms were maintained at 23 °C along 16 hours of
light and 8 hours of dark, checked every 24 hours - where endpoints were registered and
the dead organisms were removed to prevent bacterial contaminations and consequently
influencing the results.
Fe3O4 and Fe3Se4 nanoparticles were evaluated with dopamine and levodopa coatings.
It was not possible yet to evaluate the surface functionalization with the Gadolinium
complexes described in Chapter 3: Applications, due to the timing of this thesis. Assays
to evaluate the effect of the nanoparticles without surface coatings were not possible to
perform due to the impossibility of dispersing hydrophobic nanoparticles in FETAX.
Previous studies have been conducted to evaluate in vivo toxicological effects of Fe3O4
nanoparticles with different coatings. Results show that Fe3O4 nanoparticles do not
have significant toxic effects, demonstrating good biocompatibility [87,88].
Results and Discussion
The ecotoxicological evaluation is still in the beginning, so the results presented here are
merely preliminary and should serve as a base to built upon for future reference. It is
very clear that these results are in no way prepared for a publication, and further assays
and biomarker studies need to be performed.
3In order to maintain a similar environment for the organisms, nanoparticles were dispersed directly
on FETAX so that only these would be considered as invaders.
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Fe3O4 @ Dopamine
Figure 24 shows the average cumulative mortality of Xenopus laevis tadpoles exposed to
different concentrations of Fe3O4 nanoparticles functionalized with dopamine (Fe3O4 @
Dopamine) during 72 hours. Comparing the mortality values of the control population
with the ones of tadpoles submitted to the presence of nanoparticles, the results appear
to be similar. At lower concentrations, from 46.2 to 55.5 mg/L the particles seem to have
no effect on the mortality of these organisms. With concentrations above 66 mg/L, the
results indicate that these nanoparticles can, in fact, induce death or mobility problems
that can later lead to death.
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Figure 24 – Average cumulative mortality of Xenopus laevis tadpoles exposed during 72 hours to a series
of concentrations of Fe3O4 @ Dopamine nanoparticles. Error bars represent standard deviation.
Fe3O4 @ Levodopa
Figure 25 shows the average cumulative mortality of Xenopus laevis tadpoles exposed
to different concentrations of Fe3O4 nanoparticles functionalized with Levodopa (Fe3O4
@ Levodopa) during 72 hours. Fe3O4 @ Levodopa nanoparticles appear to affect the
organisms more than what it was noticed in Fe3O4 @ Dopamine nanoparticles - although,
at this point, these differences cannot be discussed due to lack of information. Figure
26 shows images of Xenopus laevis tadpoles while in the presence of Fe3O4 @ Levodopa
nanoparticles.
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Figure 25 – Average cumulative mortality of Xenopus laevis tadpoles exposed during 72 hours to a series
of concentrations of Fe3O4 @ Levodopa nanoparticles.
Figure 26 – Xenopus laevis in the presence of Fe3O4 @ Levodopa nanoparticles
Fe3Se4 @ Dopamine
Figure 27 shows the average cumulative mortality of Xenopus laevis tadpoles exposed to
different concentrations of Fe3Se4 nanoparticles functionalized with dopamine (Fe3Se4
@ Dopamine) during 72 hours. In the presence of these nanoparticles, even at small
concentrations (1.953 mg/L), the mortality seems to be superior after 72 hours than after
24 hours. This shows that the nanoparticles tend to have an over time accumulation
effect, not an immediate one. Figure 28 shows images of Xenopus laevis tadpoles while
in the presence of Fe3Se4 @ Dopamine nanoparticles.
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Figure 27 – Average cumulative mortality of Xenopus laevis tadpoles exposed during 72 hours to a series
of concentrations of Fe3Se4 @ Dopamine nanoparticles. Error bars represent standard deviation.
Figure 28 – Xenopus laevis tadpoles in the presence of Fe3Se4 @ Dopamine nanoparticles
Fe3Se4 @ Levodopa
Figure 29 shows the average cumulative mortality of Xenopus laevis tadpoles exposed
to different concentrations of Fe3Se4 nanoparticles functionalized with levodopa (Fe3Se4
@ Levodopa). It is noticeable that Fe3Se4 nanoparticles can induce death in smaller
concentrations than Fe3O4 nanoparticles. Also, these nanoparticles seem to have an
effect over time, once the average mortality tends to increase over time. In the majority
of analysed concentrations (above 4.4 mg/L), the mortality values reached 80-90%.
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Figure 29 – Average cumulative mortality of Xenopus laevis tadpoles exposed during 72 hours to a series
of concentrations of Fe3Se4 @ Levodopa nanoparticles. Error bars represent standard deviation.
Figure 30 – Xenopus laevis tadpoles in the presence of Fe3Se4 @ Levodopa nanoparticles
During the observations of these assays, it was noticed that the nanoparticles tend to
aggregate around the tadpole and link onto its skin. This often occurs in Fe3Se4
nanoparticles (as seen in Figures 28 and 30), which can be due to its larger size
(>300 nm), when compared to Fe3O4 (<20 nm). The aggregation around the tadpoles
often leads to induced malformations and moving difficulties, which can also explain
why Fe3Se4 nanoparticles increases mortality at smaller doses. The coating of the
nanoparticles was also a differentiation factor: the levodopa coated nanoparticles
appear to increase mortality at smaller doses when compared to dopamine coated
nanoparticles.
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These studies will be continued, in the scope of the student’s thesis, and other species
will be evaluated in order to obtain clearer results.
4.2 In Vitro cytotoxic evaluation
Dopamine coated Fe3Se4 nanoparticles in vitro cytotoxicity was evaluated in 2D cultures
of prostate cancer cells grown in complete cell culture medium. For cytotoxicity assays
cells were then sub-cultured in 96 well plates. After 24 hours, the culture medium was
removed, and cells were incubated with different nanoparticle concentrations in reduced
medium for 4 hours. Afterwards, cell culture medium was removed, and cell viability was
evaluated at 24 hours using the non-radioactive Alamar Blue® assay. For this purpose,
cell were incubated with Alamar Blue® reagent for 4 hours. The fluorescence of the
resulting resorufin was measured at an excitation/emission of λex = 540 nm / λem =
600 nm by using a multi-mode microplate reader equipped with a tungsten halogen lamp.
Nanoparticle incubated cells were imaged after 24 hours following incubation by using
an optical contrast microscope. As shown in Figure 31, Fe3Se4 nanoparticles do not
elicit a cytotoxic response in PC-3 cells, however it is important to emphasize that
nanoparticles precipitate in culture medium. Hence the cytotoxicity data obtained by
Alamar Blue® assays should be carefully evaluated since the nanoparticles may have
not entered PC-3 cells. The fact that the nanoparticles aggregated around the cells
may be interesting for cell-binding applications. Furthermore, in order to design the
nanoparticles for internalizing their surfaces should be modified, for example, with
proteins.
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Figure 31 – Fe3Se4 nanoparticles cytotoxicity characterization. (a) Alamar blue
® analysis of PC-3
cells viability upon incubation with Fe3Se4 nanoparticles. Data is represented as mean ± s.d. (n =5). K-
represents PC-3 cells non-incubated. Optical contrast micrographs of PC-3 cells: (b) control, i.e., non-
incubated with nanoparticles; (c) Fe3Se4 nanoparticles 5 µg/mL; (d) Fe3Se4 nanoparticles 10 µg/mL;
(e) Fe3Se4 nanoparticles 100 µg/mL; (f) Fe3Se4 nanoparticles 250 µg/mL; (g) Fe3Se4 nanoparticles 500
µg/mL;
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5. Conclusions and Outlook
In the beginning, this thesis was focused on the development of magnetic nanoparticles
to act as contrast agents for MRI. In order to achieve this, Fe3O4 and Fe3Se4
nanoparticles were synthesized and characterized. The development included the
synthesis, characterization and the surface coating procedures that were specially
developed to achieve a phase exchange and a functionalization in just one step. The
synthesis of Fe3O4 nanoparticles is widely studied and used by scientists all over the
world. Still, the one step phase exchange and surface functionalization methods here
reported represent a simplified green surface coating procedure, which may be used in
several biomedical applications, specially ones that require small surface coatings. On
the other hand, the synthesis of Fe3Se4 nanoparticles here presented appears to be one
of pioneer methods for this specific inorganic phase. In fact, it took approximately 2
years to improve the synthesis methods of Fe3Se4 nanoparticles, and there are still
details to be perfected.
At a certain point came the idea of using Fe3Se4 nanoparticles as logic gates that
respond to temperature and magnetic field as inputs, due to its TC slightly above room
temperature. Given the collaboration with Dr. Vítor Gaspar and Professor João Mano,
it was possible to evaluate the behaviour of Fe3Se4 nanoparticles in hyperthermia
cellular assays, which proved to be successful in determining whether or not the cells
were heated up above 40 °C.
During this time, and regarding the MRI application, Gadolinium-based metal-organic
complexes, with dopamine and levodopa, were developed in order to further be used
as a surface coating for Fe3O4 nanoparticles. Although the metal-organic synthesis
were achieved successfully, the surface functionalization of nanoparticles only worked for
Gadolinium DTPA-bislevodopa. There is no current explanation for this, but hopefully
this obstacle will be overcome and the Gadolinium DTPA-bisdopamine will soon be
anchored onto the surface of Fe3O4 nanoparticles.
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The in vivo ecotoxicological evaluation was performed in collaboration with Pedro Nunes,
a Master student supervised by Dr. Isabel Lopes from the University of Aveiro. The
majority of replicas showed that the nanoparticles tend to aggregate in the biological
medium and around the organisms, leading them to develop malfunctions and disturb
their typical movement. For now, this study is not deeply explored, but hopefully will
soon answer some questions about the interaction between the nanoparticles and its
effects on living beings.
The in vitro cytotoxic evaluation was performed in collaboration with Dr. Vítor Gaspar.
This study agrees with the previous one, as the observations show that the majority of
the nanoparticles tend to aggregate in biological mediums and link onto the surface of
cells and living beings.
There is still room to grow, as always. With that in mind, the planned future work
includes:
• The use of Fe3O4 nanoparticles mixed with Fe3Se4 nanoparticles in order to Fe3O4
nanoparticles act as heat sources, and Fe3Se4 nanoparticles act as thermometers.
• The preparation of dual-mode contrast agents with a variety of known
concentrations in order to evaluate the NMR signal according to concentration of
contrast agents.
• The in vivo ecotoxicological evaluation studies are still currently being developed,
and there are several tasks to do regarding this topic. As of this moment, studies
on P. perezi, the most common amphibian in Portugal, are being conducted. These
studies are specially important for nanoparticles that can later be used as contrast
agents, i.e. need to enter the organism and still be harmless.
• Several sub-cellular parameters will be tested, using the evaluation of two types
of biological biomarkers. These markers can be considered as main endpoints on
toxicity effects.
• The in vivo ecotoxicological evaluation of the prepared Gadolinium complexes and
its combination with Fe3O4 nanoparticles, as well as the evaluation of the effects
of Dopamine and Levodopa without the presence of nanoparticles.
• The in vitro cytotoxic evaluation are currently being developed in order to have a
complete analysis of all the nanoparticles and surfaces.
In summary, this thesis led to the development of what can be considered parallel
research projects, all of them including the development and functionalization of
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magnetic nanoparticles. As a personal opinion, this thesis lifts the veil on several
questions regarding the development of different dual-mode contrast agents, and the
advance on temperature control on hyperthermia assays. With that in mind, this thesis
will hopefully be used as a starting platform giving rise to new projects.
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A. Appendix
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Figure A1 – Solid State 13C NMR of DTPA bis anhydride.
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Figure A2 – Solid State 13C NMR of DTPA bis dopamine.
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Figure A3 – Solid State 13C NMR of DTPA bis levodopa.
A.2 Experimental
A.2.1 X-ray Diffraction
X-ray diffraction (XRD) measurements were performed at room temperature with a
PANalytical Empyrean powder diffractometer using monochromated CuKα radiation (λ
= 1.541 °A) in the 10-100 °(2θ) range at 0.02 °resolution, and 4000 acquisition points per
step. The incident beam optics included a Soller slit of 0.04 rad, a 10 mm fixed mask,
a divergence fixed slit of 1/4 and an anti-scatter slit of 1/8. The diffracted beam optics
included a Soller slit of 0.04 rad and anti-scatter slit of 7.5 mm. The analysis of the
diffraction patterns was performed by Rietveld refinement using the FullProf package.
The size effects were treated with the integral breadth method using the Voigt model
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for both the instrumental and intrinsic diffraction peak shape considering a Thompson-
Cox-Hastings pseudo-Voigt convoluted with Axial divergence asymmetry function to
describe the peak shape. The contribution of the instrument to the peaks broadening
was determined by the refinement of the XRD pattern of a LaB6 standard sample (NIST
ref. 660a).
A.2.2 Infrared Spectroscopy
Infrared spectra (FTIR) were obtained in a FTIR Brucker Tensor 27 equipped with an
OPUS® (V4.5) software, in the wavenumber range of 4000-350 cm−1, with 100 scans
and 4 cm−1 resolution. All the samples were placed under the beam without any prior
modification.
A.2.3 Transmission Electron Microscopy
Transmission electron microscopy (TEM) on the nanoparticles was performed using a
Hitachi H9000 microscope, working at 300 kV. Scanning Transmission Electron
Microscopy - High Angle Annular Dark Field (STEM-HAADF) images were obtained
in a probe-corrected Titan (FEI) at a working voltage of 300 kV, coupled with a
HAADF detector (Fischione). Samples for TEM observations of the nanoparticles
dispersed in the ferrofluids were prepared by dip coating of carbon coated copper grids.
A.2.4 Cell culture and studies on cells
Prostate cancer cells (PC-3) were routinely cultured in RPMI-1640 medium
supplemented with 10% FBS and 1% antibiotic/antimycotic. PC-3 cells were grown in
cell culture treated t-15 flasks in a temperature-controlled incubator at 37 °, 5% CO2
and in a humidified atmosphere. Upon reaching confluency cells were detached by
using TripLETMXpress and subcultured. µ-slide angiogenesis Ibidi imaging chambers
(Ibidi GmBH, Germany), were coated with a nanoparticle suspension until a uniform
layer was formed. Subsequently, MatrigelTM was deposited on top of the nanoparticle
layer and allowed to crosslink at 37 °C for 2h. This dual deposition strategy allowed
for the formation of a cell adhesive substrate for PC-3 cells proliferation. Prostate
cancer cells were then seeded at a density of 1:3 ×105 cells/cm2 and allowed to
proliferate during 24 h. Irradiation was performed using a 850 NIR Led (Oslon
PowerStar) with a power density 228 and 570 mW/cm2 (according to specifications)
during 5 min. The Fe3Se4 nanoplatelets on the wells were magnetized (set in a high
state) using a cylindrical neodymium-iron-boron magnet (diameter 8 mm, height 30
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mm, N42). The state before and after the irradiation procedures were measured using
a F fluxgate magnetometer (FL1-100 Stefan Mayer Instruments) embedded in a
permalloy foil to decrease the ambient magnetic field and noise at the fluxgate. On the
following day cells were incubated with Calcein-AM/PI for 30 min at 37 °C. The cells
were then washed 3 times with PBS and imaged.
A.2.5 Fluorescence Miscrocopy
Cells were then washed 3 times with PBS and imaged in a Zeiss Imager M2 fluorescence
microscope (Carl Zeiss Microscopy GmbH, Germany), equipped with a 10x/0.25 air
objective. All the data was processed in the Zeiss Zen software (Carl Zeiss Microscopy
GmbH, Germany).
A.2.6 Magnetic data
Magnetic measurements were performed in a superconducting quantum interference
device (SQUID) magnetometeres model MPMS-XL and MPMS3, from Quantum
Design Inc, under helium atmosphere.
A.2.7 Magnetis Resonance Imaging
The 1H NMR technique was used to measure the longitudinal and transverse relaxivities
in a wide range of frequencies covering most of the clinical imagers (µ ≈ 8.5, 21, and 63
MHz correspondingto about 0.2, 0.5, and 1.5 T, respectively). For ≤ 10 kHz µ ≤ 10 MHz,
the NMR data were collected with a Smartracer Stelar relaxometer (Stelar, Mede, Italy)
using the Fast-Field-Cycling technique, while for n > 10 MHz a Stelar Spinmaster and an
Apollo-Tecmag spectrometers have been used (Tecmag, Houston, TX). Standard radio-
frequency excitation sequences Carr-Purcell-Meiboom-Gill-like and saturation recovery
were applied to deter-mine T2 and T1 values.
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